Single-incision robotic radical prostatectomy independent of special multi-channel port
NIE Yu1, CHEN Zhengjun1, ZHOU Fang1, REN Shangqing1, FAN Shida1, LV Qian1, FENG Hualin1, WANG Qiang1, LUO Cheng1, WEI Yi1, WANG Yaoqian1, OU Yong1, WANG Dong1
1Robotic Minimally Invasive Surgery Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, China
Abstract:Objective: To assess the feasibility and validity of single-incision robot-assisted laparoscopic radical prostatectomy independent of special multi-channel port. Method: From November 2020 to February 2021, 51 consecutive patients with biopsy confirmed prostate cancer underwent extraperitoneal robot-assisted laparoscopic radical prostatectomy, independent of multichannel port. The median age was 68 (interquartile range [IQR], 58-80) years old; Gleason score was ≤7 in 40 cases, ≥8 in 11 cases, and the median prostate volume was 54 (IQR, 24.0-200.0 mL); clinical stage was <cT3a in 49 cases, cT3a in 2 cases; 21 cases had a history of surgery. Data were collected and analyzed, including the time of the channel establishment and docking, operation time, blood loss, retention time of urinary catheter, restoration of intestinal function, complications, pathology, surgical cost and related follow-up results. Result: All the operations were successfully performed as planned. The median time of channel establishment and docking was 27 (IQR, 21-47) min; the median operation time was 60.7 (IQR, 37-123) min; the median intraoperative bleeding was 77 (IQR, 42-228) mL; the median time of intestinal exhaust was 1.0 (IQR, 0.5-3) d; the median time of catheter retention was 6.9 (IQR, 6-14) days; the median time of postoperative hospital stay was 7.2 (IQR, 6-15) days. No complication of level Ⅱ-V occurred. Postoperative Gleason score was ≤7 in 38 cases, and 8 in 13 cases; postoperative pathological staging was <pT3a in 34 cases, ≥pT3a in 17 cases. Obturator lymph node dissection was performed on 11 cases and all of them were negative; 9 cases had positive margin, and 1 case had positive urethral stump. Totally, 23 patients had immediate continence when urinary catheter was removed, and 31 patients had satisfactory continence within 1 month after surgery. PSA was <0.2 μg/L in 28 cases at 4th week, 21 cases at 8th week, and 10 cases at 12th week after surgery. The erectile function recovered in 2 cases, and returned to the preoperative level in one case, and one case had erectile function. The cost of surgery was reduced by an average of 6 000 Yuan RMB (the cost of special multi-channel port). Conclusion: Single-incision robot-assisted laparoscopic radical prostatectomy independent of special multi-channel port is a feasible and safe surgical option. In our early experience, promising results and possible advantages were found, including no special multi-channel port, significant cost savings, and satisfactory curative effect, etc.
[1] MILLIN T.Retropubic prostatectomy: a new extravesical technique on report of 20 cases. Lancet, 1945,2(6380):693-696.
[2] WALSH PC.The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol, 2007,177(5):1632-1635.
[3] SCHUESSLER WW, SCHULAM PG, CLAYMAN RV, et al.Laparoscopic radical prostatectomy: initial short-term experience. Urology, 1997,50(6):854-857.
[4] BINDER J, KRAMER W.Robotically-assisted laparoscopic radical prostatectomy. BJU Int, 2001,87(4):408-410.
[5] KAOUK JH, GOEL RK, HABER GP, et al.Robotic single-port transumbilical surgery in humans: initial report. BJU Int, 2009,103(3):366-369.
[6] 周晓晨,胡兵,傅斌,等.3种机器人辅助腹腔镜根治性前列腺切除术手术入路对比研究:前入路,后入路及经膀胱入路.临床泌尿外科杂志,2019,34(7):501-506.
[7] GROEBEN C, WIRTH MP.Prostate cancer: Basics on clinical appearance, diagnostics and treatment. Med Monatsschr Pharm, 2017,40(5):192-201.
[8] SRIDHARAN S, MACIAS V, TANGELLA K, et al.Prediction of prostate cancer recurrence using quantitative phase imaging. Sci Rep, 2015,5(5):9976.
[9] SU LM.Robot-assisted radical prostatectomy: advances since 2005. Curr Opin Urol, 2010,20(2):130-135.
[10] 王林辉. 机器人辅助腹腔镜技术在泌尿外科的临床应用:中国15年数据分析.第二军医大学学报,2020,41(7):697-700.
[11] 陈晶,梁朝朝,周骏,等.达芬奇机器人辅助腹腔镜泌尿外科手术500例回顾性分析.微创泌尿外科杂志,2018,7(2):77-82.
[12] DU Y, LONG Q, GUAN B, et al.Robot-Assisted radical prostatectomy is more beneficial for prostate cancer patients: a system review and Meta-Analysis. Med Sci Monit, 2018,24(1):272-287.
[13] 许晖阳,莫承强,陈炜,等.机器人辅助腹腔镜手术治疗高危前列腺癌的初步应用研究.微创泌尿外科杂志,2017,6(1):51-54.
[14] 王林辉,吴震杰,朱清毅.中国泌尿外科单孔腹腔镜技术的发展与展望.中华泌尿外科杂志,2020,41(11):807-810.
[15] 张旭,马鑫,朱捷,等.经脐单孔腹腔镜肾切除术2例报告.临床泌尿外科杂志,2009,24(8):568-571.
[16] 张旭,马鑫,李宏召,等.单孔后腹腔镜解剖性肾上腺切除术5例报告.临床泌尿外科杂志,2009,24(9):647-650.
[17] 吴震杰,王坚超,王杰,等.机器人单孔腹腔镜肾上腺肿瘤切除术初步临床应用报告.临床泌尿外科杂志,2017,32(6):437-439,443.
[18] 杜巍,徐伟东,杨悦,等.多种路径机器人辅助单孔腹腔镜根治性前列腺切除术的初步疗效.中华泌尿外科杂志,2020,41(11):815-819.
[19] MOSCHOVAS MC, SEETHARAM BK, ONOL FF, et al.Single-port technique evolution and current practice in urologic procedures. Asian J Urol, 2021,8(1):100-104.
[20] 任尚青,吕倩,冯华林,等.经腹腔途径与经腹膜外单孔途径RARP的临床疗效对比.中华泌尿外科杂志,2021,42(2):181-185.